CoChat

MORGAM (an international pooling of cardiovascular cohorts)

Open access
Evans, A. · 2004 · International Journal of Epidemiology
Cited by 128

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Dissatisfaction has been voiced over recent decades concerning the lack of a relevant cardiovascular disease (CVD) scoring system for European populations. Recently this deficiency has been repaired with the publication of SCORE,1 although nonfatal events are still not catered for. In addition, the entire sequence of the human genome has recently been published.2 Common chronic diseases, such as coronary heart disease (CHD) and stroke, may have a strong genetic component. They are, however, caused not by a single genetic defect but by the interactions of many genetic and environmental factors. Hence, they are often called complex, multifactorial diseases. Moreover, the biological effects of common genetic variants are likely to be small in magnitude; indeed, variants with large biological effects tend to be rare, for example familial hypercholesterolaemia. Investigators examining the genetic background of complex, multifactorial diseases should, therefore, realize that they are looking for interactions between genetic variants with small, or at most moderate, effects. It is obvious that the reliable detection of these effects requires large sample sizes and abundant statistical power, which can be achieved only in a large collaborative study using high-throughput genotyping. It should be emphasized, however, that moderate and even small effects can carry considerable public health significance if the genetic variants in question are common in the population. The remarkable success of the Human Genome Project has been possible only through the multinational collaboration of several research laboratories and the open exchange of information through the Internet. Developments in genetics open up new possibilities for the prevention and treatment of chronic diseases, but to capitalize on this potential, a better understanding of the significance of genetic variation and the interactions of genetic variants with environmental factors is needed. Towards the end of the WHO MONICA Project3 it was realized that a follow-up of the cohorts recruited by the project would be ideal for exploring both issues mentioned above. This follow-up project was established under the name MORGAM (MONICA, Risk, Genetics, Archiving, and Monograph; www.ktl.fi/morgam) and now also includes cohorts from non-MONICA centres. It was initially funded under the Fourth Framework Programme of the European Union. Two of its components, archiving and monograph, have been completed. This profile describes the remaining two, risk and genetics, both of which are based on the pooling of prospective CVD cohorts. For a subset of these cohorts DNA is available and central collation, preparation and genotyping in a case–cohort setting are well under way. Since 2002, these activities have become a component of GenomEUtwin (www.genomeutwin.org), a Network of Excellence for Genomics in Europe, funded under the Fifth Framework Programme. Centres have recruited their cohorts and organized the follow-up locally using their own funding. MORGAM is pooling these cohorts, and the funding is devoted to co-ordination, pooling of samples and data, quality assessment and control, central preparation of DNA, and laboratory analysis. Support for the participating centres is through access to their own results, the return of surplus prepared DNA, a modest subvention to support data preparation and sample handling, and attendance at an annual workshop. MORGAM has a Coordinator (A.E.) who also chairs the MORGAM Management Group, on which the participating laboratories, the MORGAM Data Centre at the Finnish National Public Health Institute (KTL) in Helsinki, and the GenomEUtwin Coordinator are represented. MORGAM was designed with the overall aim of eventually studying a limited number of well-defined phenotypes and several hundred genetic factors simultaneously by pooling the risk-factor data collected in the MONICA cross-sectional surveys, adding follow-up and genotyping, and including other relevant cohorts. The main objective of the risk-factor component of the study is to assess the similarity of risk coefficients for the classic CVD risk factors in different parts of Europe, between men and women, and between age groups using large cohorts with standardized baseline measurements and carefully validated fatal and nonfatal CHD and stroke end-points. Furthermore, the data will be used to derive European risk scores and to assess the impact of socioeconomic and other factors for which data are available in the cohorts. The MORGAM genetic component, which employs a case–cohort design, will provide a framework for the analysis of the associations among genetic variants, risk-factor phenotypes, and disease events. This could also allow an assessment of gene–gene and gene–environment interactions. The identification of meaningful combinations of genotypes and environmental factors will rely heavily on the use of appropriate mathematical models and statistical techniques. The

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/dyh327

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 128

Metadata

Authors
Evans, A.
Venue
International Journal of Epidemiology
Published
2004-08-27
Volume
34
Issue
1
Pages
21-27
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2116071862
Cited by
128
References
3
FWCI
2.69
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MORGAM (an international pooling of cardiovascular cohorts). https://app.cochat.ai/papers/10.1093/ije/dyh327
The paper
Evans, A. (2004). MORGAM (an international pooling of cardiovascular cohorts). International Journal of Epidemiology. https://doi.org/10.1093/ije/dyh327

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.